Home/Filings/4/0001814899-25-000003
4//SEC Filing

Lloyd George W. 4

Accession 0001814899-25-000003

CIK 0001802768other

Filed

Nov 6, 7:00 PM ET

Accepted

Nov 7, 4:18 PM ET

Size

9.7 KB

Accession

0001814899-25-000003

Insider Transaction Report

Form 4
Period: 2025-11-05
Lloyd George W.
EVP, Investments & CLO
Transactions
  • Award

    Class A Ordinary Shares

    2025-11-05+6,16858,510 total(indirect: By LLC)
Holdings
  • Class A Ordinary Shares

    (indirect: By LLC)
    495,860
  • Class A Ordinary Shares

    (indirect: By IRA)
    273,960
  • Class A Ordinary Shares

    (indirect: By LLC)
    52,000
  • Class A Ordinary Shares

    (indirect: By Spouse)
    4,011.19
  • Class A Ordinary Shares

    3,000
  • Class A Ordinary Shares

    (indirect: By LLC)
    220,000
  • Class A Ordinary Shares

    (indirect: By LLC)
    28,000
Footnotes (1)
  • [F1]Reflects the exempt acquisition by the Reporting Person pursuant to Rule 16b-3 of Class A Ordinary Shares of the Issuer in connection with the settlement of Equity Performance Awards.

Issuer

Royalty Pharma plc

CIK 0001802768

Entity typeother

Related Parties

1
  • filerCIK 0001814899

Filing Metadata

Form type
4
Filed
Nov 6, 7:00 PM ET
Accepted
Nov 7, 4:18 PM ET
Size
9.7 KB